cIAP-2 is known to be upregulated in NSCLC [86], whereas chemotherapy induces cIAP-1 up-regulation [87], suggesting an important adaptive role of these two proteins in response to anti-cancer drugs treatments. This evidence concerns the gene BIRC3 and non-small cell lung carcinoma.